Affiliation:
1. Central Department of Chemistry, Tribhuvan University, Kirtipur 44618, Kathmandu, Nepal
2. School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea
3. Institute of Biomolecule Reconstruction (iBR), Department of Life Science and Biochemical Engineering, Sun Moon University, Asan 31460, Republic of Korea
Abstract
Streptomyces are well-known for producing bioactive secondary metabolites, with numerous antimicrobials essential to fight against infectious diseases. Globally, multidrug-resistant (MDR) microorganisms significantly challenge human and veterinary diseases. To tackle this issue, there is an urgent need for alternative antimicrobials. In the search for potent agents, we have isolated four Streptomyces species PC1, BT1, BT2, and BT3 from soils collected from various geographical regions of the Himalayan country Nepal, which were then identified based on morphology and 16S rRNA gene sequencing. The relationship of soil microbes with different Streptomyces species has been shown in phylogenetic trees. Antimicrobial potency of isolates was carried out against Staphylococcus aureus American Type Culture Collection (ATCC) 43300, Shigella sonnei ATCC 25931, Salmonella typhi ATCC 14028, Klebsiella pneumoniae ATCC 700603, and Escherichia coli ATCC 25922. Among them, Streptomyces species PC1 showed the highest zone of inhibition against tested pathogens. Furthermore, ethyl acetate extracts of shake flask fermentation of these Streptomyces strains were subjected to liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis for their metabolic comparison and Global Natural Products Social Molecular Networking (GNPS) web-based molecular networking. We found very similar metabolite composition in four strains, despite their geographical variation. In addition, we have identified thirty-seven metabolites using LC-MS/MS analysis, with the majority belonging to the diketopiperazine class. Among these, to the best of our knowledge, four metabolites, namely cyclo-(Ile-Ser), 2-n-hexyl-5-n-propylresorcinol, 3-[(6-methylpyrazin-2-yl) methyl]-1H-indole, and cyclo-(d-Leu-l-Trp), were detected for the first time in Streptomyces species. Besides these, other 23 metabolites including surfactin B, surfactin C, surfactin D, and valinomycin were identified with the help of GNPS-based molecular networking.
Reference129 articles.
1. Antimicrobial Resistance Is a Global Health Emergency;Toner;Health Secur.,2015
2. Metabolomics: An Emerging but Powerful Tool for Precision Medicine;Clish;Cold Spring Harb. Mol. Case Stud.,2015
3. Zhou, B., Xiao, J.F., Tuli, L., and Ressom, H.W. (2012). LC-MS-Based Metabolomics. Mol. Biosyst., 8.
4. Molecular Networking as a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy;Quinn;Trends Pharmacol. Sci.,2017
5. Novel Bioactive Compounds from Actinomycetes: A Short Review (1988–1992);Sanglier;Res. Microbiol.,1993
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献